Hangzhou Polymed Biopharmaceuticals, Inc.
Clinical trials sponsored by Hangzhou Polymed Biopharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Two-Pronged pill outsmart stubborn leukemia? Results expected Jun 2027 (estimated)